BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22222125)

  • 1. Which pulmonary function tests best differentiate between COPD phenotypes?
    Salzman SH
    Respir Care; 2012 Jan; 57(1):50-57; discussion 58-60. PubMed ID: 22222125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the clinical value of lung volumes?
    Ruppel GL
    Respir Care; 2012 Jan; 57(1):26-35; discussion 35-8. PubMed ID: 22222123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making the diagnosis of asthma.
    McCormack MC; Enright PL
    Respir Care; 2008 May; 53(5):583-90; discussion 590-2. PubMed ID: 18426612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological differences and similarities in asthma and COPD--based on respiratory function testing.
    Mishima M
    Allergol Int; 2009 Sep; 58(3):333-40. PubMed ID: 19628977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality in COPD.
    Celli BR
    Respir Med; 2010 Jun; 104(6):773-9. PubMed ID: 20417082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.
    Casanova C; Cote C; de Torres JP; Aguirre-Jaime A; Marin JM; Pinto-Plata V; Celli BR
    Am J Respir Crit Care Med; 2005 Mar; 171(6):591-7. PubMed ID: 15591470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical therapy for chronic obstructive pulmonary disease.
    Martinez FJ; Chang A
    Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
    Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
    Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of lung transplantation on pulmonary function in 5 patients with chronic obstructive pulmonary disease].
    Liu JM; Yang WL; Jiang GN; Ding JA; Wang YM; Zheng W; Zhu D; Gao BL; Jiang P; Wu W
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Aug; 28(8):509-12. PubMed ID: 16207394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating COPD from asthma in clinical practice.
    Chang J; Mosenifar Z
    J Intensive Care Med; 2007; 22(5):300-9. PubMed ID: 17895488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function testing.
    Ruppel GL; Enright PL
    Respir Care; 2012 Jan; 57(1):165-75. PubMed ID: 22222135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic goals and outcome measurements in COPD patients].
    Morr H
    Med Klin (Munich); 2006 Apr; 101(4):279-82. PubMed ID: 16607483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional capacity (dyspnea) and quality of life in patients with chronic obstructive lung disease (COPD): instruments of assessment and methodological aspects].
    Hütter BO; Würtemberger G
    Pneumologie; 1999 Mar; 53(3):133-42. PubMed ID: 10226475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases.
    Budweiser S; Meyer K; Jörres RA; Heinemann F; Wild PJ; Pfeifer M
    Eur J Clin Nutr; 2008 Mar; 62(3):436-43. PubMed ID: 17342162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.